1 0

    FDA Drug Approval, A212025, APOMORPHINE HYDROCHLORIDE

    FDA Drug Approval, A212025, APOMORPHINE HYDROCHLORIDE

    $149.00 USD
    $149.00 USD
    Sale Sold out

    Contents: CMC section from the Summary Basis of Approval; Clinical Review Summary; and Review Package including any evaluation of the product.

    ANDA: 212025
    Company: SAGE CHEMS
    Drug Name: APOMORPHINE HYDROCHLORIDE
    Active Ingredients: APOMORPHINE HYDROCHLORIDE
    Strength: 30MG/3ML (10MG/ML)
    Dosage Form/Route: INJECTABLE;SUBCUTANEOUS
    Action Date: 02/23/2022
    Marketing Status: Prescription
    Submission Classification: ORIG-1 TE Code: AP

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details